pope can't, on paper at least, influence the PPS with buys or sells John.. Although pope would have a sense of responsibility to their client, (investor) that GTEC is valued for more.. Pope has no liability, but reputation to up-hold, so it's in Pope's best interests that GTEC bounces back..
What GTEC can do to influence PPS is what most have been asking for,, greater public exposure.. which is the main reason people want to up-list too, exposure..
and we have several variables coming which will increase the exposure.. 1 drug on the edge of manufacture, another right behind it, then 2 more... and the fifth, a chain of products for,, the next 18 months or there about..
Plus,, this could be one of a few reasons for the critical timing of this past loan besides needing to get the fifth drug paid off.. you need the equipment to expand production... (note loan PR) set-up and ready to roll.. and as we saw with the last product a heavy advertising campaign..
Five new drugs all falling into place, expansion and exposure equally in balance. seems to be the ticket...
Corn-fused-us Long-vestor ancient saying: Patience and small movements keep a steady course.
News 
Market Data 
Discover 
